section name header

Pronunciation

koe-le-SEV-e-lam

Classifications

Therapeutic Classification: lipid-lowering agents

Pharmacologic Classification: bile acid sequestrants

Indications

REMS


Action

  • Binds bile acids in the GI tract.
  • Results in increased clearance of cholesterol.
  • Mechanism for lowering blood glucose unknown.
Therapeutic effects:
  • Decreased cholesterol and blood glucose.

Pharmacokinetics

Absorption: Not absorbed; action is primarily local in the GI tract.

Distribution: Unknown.

Metabolism/Excretion: Unknown.

Half-Life: Unknown.

Time/Action Profile

(cholesterol-lowering effect)

ROUTEONSETPEAKDURATION
PO24–48 hr2 wkunknown





Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

GI: constipation, dyspepsia

Interactions

Drug-drug:

Route/Dosage

Hyperlipidemia

Type 2 Diabetes

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Welchol

Canadian Brand Names

Lodalis